Key facts
- This page summarizes Barbara Gutierrez's Form 4 filing for ModivCare Inc (MODV).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Feb 2024, 21:27.
Barbara Gutierrez - 14 Feb 2024 Form 4 Insider Report for ModivCare Inc (MODV)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- MODV
- Reported as of
- 14 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2024, 21:27:02 UTC
- Prior SEC filing
- 23 Jan 2024
- Next SEC filing
- 05 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Jaskolka by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Barbara Gutierrez filed Form 4 for ModivCare Inc (MODV) on 22 Feb 2024.
Change
- Previous filing in this sequence was filed on 23 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MODV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +6,134
- Change %
- +72%
- Price
- $0.000000
- Shares after
- 14,707
- Date
- 14 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MODV
transaction
Derivative
Performance Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +9,202
- Change %
- Price
- $0.000000
- Shares after
- 9,202
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,202
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents restricted stock units scheduled to vest as follows: (i) 2,045 shares will vest on February 14, 2025, (ii) 2,044 shares will vest on February 14, 2026 and (iii) 2,045 shares will vest on February 14, 2027, in each case, subject to the reporting person's continued employment.
Footnote F2
Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units by percentages from 50% to 200% that corresponds to targeted (i) Adjusted EBITDA performance (weighted at 40%) with percentage thresholds to be measured against 2026 Company performance within a range from 80% to 120% of target, and (ii) total shareholder return ("TSR") performance (weighted at 60%) with percentage thresholds measured over the three-year period ending December 31, 2026 and based on the percentile-ranking of the Company's TSR relative to the TSR of the Company's identified peer group and ranges from the 50th percentile to the 100th percentile, subject in each instance to the reporting person's continued employment through February 14, 2027. The number of shares of common stock reported assumes an Adjusted EBITDA and relative TSR performance target achieved that corresponds to an aggregate 100% payout level.
SEC remarks
Exhibit Index: Exhibit 24 – Power of Attorney